Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

David Zaritsky, President, Brand Insights Contributor, The Agency Network

Advertisement

Articles by David Zaritsky, President, Brand Insights Contributor, The Agency Network

Disrupting Healthcare Marketing One Story at a Time

ByDavid Zaritsky, President, Brand Insights Contributor, The Agency Network
December 20th 2021

Brand Insights - Thought Leadership | Paid Program

Advertisement

Latest Updated Articles

  • Disrupting Healthcare Marketing One Story at a Time
    Disrupting Healthcare Marketing One Story at a Time

    December 20th 2021



Advertisement
Advertisement

Trending on PharmExec

1

FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B

2

FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy

3

CSL Names Deborah Waterhouse as CEO and Manager Director

4

Median Drug Launch Prices Hit $257,000 as Access Barriers Persist, ICER and West Health Report Finds

5

Pharmaceutical Executive Daily: FDA Approves Hibsago

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us